Skip to main content
Log in

Human calcitonin gene-related peptide possesses weak inhibitory potency of bone resorptionin vitro

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Synthetic human calcitonin gene-related peptide (CGRP) was examined for the action on the bonein vitro. Human CGRP inhibited bone resorption stimulated by both human parathyroid hormone and basal. The mode of inhibitory action of human CGRP seemed to be similar to that of calcitonin and the relative potency of human CGRP to inhibit bone resorption is one five-hundredth of that of human calcitonin. Thus, a novel pharmacological action of CGRP was demonstrated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304:129–135.

    Article  PubMed  CAS  Google Scholar 

  2. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM (1982) Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298:240–244

    Article  PubMed  CAS  Google Scholar 

  3. Morris HR, Panico M, Etienne T, Tippins J, Girgis SI, MacIntyre I (1984) Isolation and characterization of human calcitonin gene-related peptide. Nature 308:746–748

    Article  PubMed  CAS  Google Scholar 

  4. Fisher LA, Kikkawa DO, Rivier JE, Amara SG, Evans RM, Rosenfeld MG, Vale WW, Brown MR (1983) Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide. Nature 306:534–536

    Article  Google Scholar 

  5. Evans RM, Amara SG, Rosenfeld MG (1983) Molecular events in developmental regulation of neuroendocrine genes: characterization of the novel neuropeptide CGRP. Cold Spring Harbor Symp Quat Biol 48:413–417

    CAS  Google Scholar 

  6. Copp D (1970) Endocrine regulation of calcium metabolism. Ann Rev Physiol 32:61–85

    Article  CAS  Google Scholar 

  7. Fujii N, Yajima H, Otaka A, Funakoshi S, Nomizu M, Akaji K, Yamamoto I, Torizuka K, Kitagawa K, Akita T, Ando K, Kawamoto T, Shimonishi Y, Takao T, (1985) Application of S-I-adamantyleysteine to the synthesis of a 37-residue peptide amide corresponding to human calcitonin gene-related peptide. J Chem Soc Chem Commun, 602–603

  8. Shigeno C, Yamamoto I, Dokoh S, Hino M, Aoki J, Torizuka K, Kameyama M (1985) Identification of 1,24(R)-dihydroxyvitamin D3-like bone-resorbing lipid in a patient with cancer-associated hypercalcemia. J Clin Endocrinol Metab 61:761–768

    Article  PubMed  CAS  Google Scholar 

  9. Rittel W, Maier R, Brugger M, Kamber B, Riniker B, Sieber P (1976) Structure-activity relationship of human calcitonin III: biological activity of synthetic analogues with shortened or terminally modified peptide chains. Experientia 32:246–248

    Article  PubMed  CAS  Google Scholar 

  10. Goltzman D, Mitchell, J (1985) Interaction of calcitonin and calcitonin gene-related peptide at receptor sites in target tissues. Science 227:1343–1345

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamamoto, I., Kitamura, N., Aoki, J. et al. Human calcitonin gene-related peptide possesses weak inhibitory potency of bone resorptionin vitro . Calcif Tissue Int 38, 339–341 (1986). https://doi.org/10.1007/BF02555747

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02555747

Key words

Navigation